ERBB2 and breast carcinoma: Thirdly, HER2-low BC (breast cancer) samples showed a higher reliability of technique at the molecular level [12] and Gheni et al., 2020 published supportively that the concordance rate between their IHC and qPCR data was 94.4% [1].